Segment Information (Tables)

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Schedule of segment perfomance measures

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated Corporate			Consolidated Totals
2014
Net sales	$	160,217	$	176,425	$	173,537	$	-		$	510,179
Gross profit		48,496		36,615		29,592		-			114,703
Income before income taxes		19,710		17,557		13,273		(5,866	)		44,674
2013
Net sales	$	129,667	$	184,852	$	185,171	$	-		$	499,690
Gross profit		39,306		31,367		27,598		-			98,271
Income before income taxes		17,276		13,294		10,400		(6,420	)		34,550
2012
Net sales	$	105,249	$	162,998	$	176,141	$	-		$	444,388
Gross profit		29,932		25,472		26,628		-			82,032
Income before income taxes		11,683		8,066		10,570		(5,579	)		24,740

Schedule of net sales and gross profit by source country

Net sales and gross profit by source country for the years ended June 30, 2014, 2013 and 2012 were as follows:

	Net Sales						Gross Profit
	2014		2013		2012		2014		2013		2012
United States	$	355,715	$	326,247	$	289,630	$	82,573	$	68,964	$	58,733
Germany		84,024		92,053		82,600		22,614		19,688		14,303
Netherlands		14,869		14,513		13,738		1,581		1,693		1,706
France		29,412		38,475		33,143		4,182		4,608		3,885
Asia-Pacific		26,159		28,402		25,277		3,753		3,318		3,405
Total	$	510,179	$	499,690	$	444,388	$	114,703	$	98,271	$	82,032

Schedule of long-lived assets by geographic region

Long-lived assets by geographic region as of June 30, 2014 and June 30, 2013 were as follows:

	Long-lived assets
	2014		2013
United States	$	160,544	$	80,870
Europe		3,458		2,684
Asia-Pacific		2,042		2,213
Total	$	166,044	$	85,767